Back to Search Start Over

LBA63 PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19)

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........1a585c8260fd94b66d3e44d9de9cbf5c
Full Text :
https://doi.org/10.1016/j.annonc.2022.08.066